Ben Forbes
Impact in
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
-
- Inhalation and Respiratory Drug Delivery
Papers in
-
- Inhalation and Respiratory Drug Delivery 71
-
- Drug Solubulity and Delivery Systems 29
- Advanced Drug Delivery Systems 27
- Co-authors
- Gary P. Martin (18 shared papers)Marc B. Brown (16 shared papers)Carsten Ehrhardt (6 shared papers)Stuart A. Jones (16 shared papers)C. Grainger (3 shared papers)David Taylor (4 shared papers)Lea Ann Dailey (22 shared papers)James A. Rickard (2 shared papers)
- Journals
- International Journal of Pharmaceutics (25 papers)Molecular Pharmaceutics (12 papers)Pharmaceutical Research (9 papers)Journal of Controlled Release (8 papers)Pharmaceutics (7 papers)
- Partner nations
- United KingdomSwedenGermany
In The Last Decade
Ben Forbes
156 papers receiving 5.7k citations
Ben Forbes's Hit Papers
Peers
Comparison fields: 5 of 164
- Pharmaceutical Science 1.4k
- Pulmonary and Respiratory Medicine 1.7k
- Clinical Psychology 969
- Biological Psychiatry 109
- Biomaterials 466
Countries citing papers authored by Ben Forbes
This map shows the geographic impact of Ben Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Forbes more than expected).
Fields of papers citing papers by Ben Forbes
This network shows the impact of papers produced by Ben Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Forbes. The network helps show where Ben Forbes may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Forbes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study Hit paper breakdown → | 2016 | 1048 |
| 2 | 2006 | 310 | |
| 3 | 2005 | 260 | |
| 4 | 2005 | 236 | |
| 5 | 2007 | 180 | |
| 6 | 2000 | 120 | |
| 7 | 2020 | 116 | |
| 8 | 2020 | 114 | |
| 9 | 2003 | 110 | |
| 10 | 2021 | 100 | |
| 11 | 2015 | 99 | |
| 12 | 2010 | 94 | |
| 13 | 2012 | 94 | |
| 14 | 2007 | 82 | |
| 15 | 2002 | 78 | |
| 16 | 2014 | 74 | |
| 17 | 2008 | 63 | |
| 18 | 2012 | 62 | |
| 19 | 2002 | 61 | |
| 20 | 2017 | 60 |
About Ben Forbes
Ben Forbes is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science, Molecular Biology, Physiology and Oncology, having authored 158 papers that have together received 5.9k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (71 papers), Drug Solubulity and Delivery Systems (29 papers), Advanced Drug Delivery Systems (27 papers), Asthma and respiratory diseases (19 papers), Drug Transport and Resistance Mechanisms (12 papers), Nanoparticle-Based Drug Delivery (8 papers), Microencapsulation and Drying Processes (7 papers) and Pharmaceutical studies and practices (7 papers). The work is most often cited by research in Pharmaceutical Science (1.4k citations), Pulmonary and Respiratory Medicine (1.7k citations), Clinical Psychology (969 citations), Biological Psychiatry (109 citations) and Biomaterials (466 citations). Ben Forbes has collaborated with scholars based in United Kingdom, Sweden and Germany. Frequent co-authors include Gary P. Martin, Marc B. Brown, Carsten Ehrhardt, Stuart A. Jones, C. Grainger, David Taylor, Lea Ann Dailey, James A. Rickard, Valerie H. Curran and Robin Carhart‐Harris. Their work appears in journals such as International Journal of Pharmaceutics, Molecular Pharmaceutics, Pharmaceutical Research, Journal of Controlled Release and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.